American Well Corporation (AMWL)
NYSE NYSE Primary 
American Well (AMWL) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for American Well (AMWL) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
American Well Corporation (AMWL) Q2 2025 Earnings Call Transcript
American Well Corporation (NYSE:AMWL ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Ido Schoenberg - Chairman & CEO Mark J. Hirschhorn - Executive VP, COO & CFO Sue Dooley - Head of Investor Relations Conference Call Participants Eric R.
American Well Corporation (AMWL) Reports Q2 Loss, Beats Revenue Estimates
American Well Corporation (AMWL) came out with a quarterly loss of $1.24 per share versus the Zacks Consensus Estimate of a loss of $1.84. This compares to a loss of $3.36 per share a year ago.
American Well (AMWL) Soars 5.0%: Is Further Upside Left in the Stock?
American Well (AMWL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Why Fast-paced Mover American Well (AMWL) Is a Great Choice for Value Investors
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, American Well (AMWL) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Hims & Hers vs. Amwell: Which Telehealth Stock Is the Better Buy?
HIMS targets personalized, AI-powered care with bold obesity moves, while AMWL bets on system-wide integration via Converge and top-tier health alliances. Who wins? Let's see.
All You Need to Know About American Well (AMWL) Rating Upgrade to Buy
American Well (AMWL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Does American Well (AMWL) Have the Potential to Rally 46.51% as Wall Street Analysts Expect?
The consensus price target hints at a 46.5% upside potential for American Well (AMWL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Is American Well (AMWL) Outperforming Other Medical Stocks This Year?
Here is how American Well Corporation (AMWL) and Claritev Corporation (CTEV) have performed compared to their sector so far this year.
American Well (AMWL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for American Well (AMWL) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
American Well Corporation (AMWL) Q1 2025 Earnings Call Transcript
American Well Corporation (NYSE:AMWL ) Q1 2025 Results Conference Call May 1, 2025 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman & Chief Executive Officer Mark Hirschhorn - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Charles Rhyee - TD Cowen Jailendra Singh - Truist Stan Berenshteyn - Wells Fargo Securities LLC Eric Percher - Nephron David Larsen - BTIG Matt Shea - Needham Operator Good day, and thank you for standing by. Welcome to Amwell's First Quarter 2025 Earnings Conference Call.
American Well Corporation (AMWL) Reports Q1 Loss, Tops Revenue Estimates
American Well Corporation (AMWL) came out with a quarterly loss of $1.73 per share versus the Zacks Consensus Estimate of a loss of $3.09. This compares to loss of $5 per share a year ago.
